Oral antidiabetic drug use and associated health outcomes in cancer patients

E-ISSN： 1365-2710|41|5|524-531

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.41, Iss.5, 2016-10, pp. : 524-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP‐4 inhibitors with other oral antidiabetic drugs

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 430-434

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Post Hoc Use of Randomised Controlled Trials to Explore Drug Associated Cancer Outcomes: Methodological Challenges

Current Drug Safety, Vol. 8, Iss. 5, 2013-11 ,pp. : 371-378

Bentham Science Publishers

Access to resources Recommend Favorite

Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 294-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral antidiabetic drug therapy in type 2 diabetes mellitus - focus on elderly patients

By Lechleitner Monika

Wiener Medizinische Wochenschrift, Vol. 161, Iss. 11-12, 2011-06 ,pp. : 297-299

Springer Publishing Company

Access to resources Recommend Favorite

Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

By Mitchell Beth D. Eby Elizabeth L. Lage Maureen J.

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1587-1597

Informa Healthcare

Access to resources Recommend Favorite